Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [Accesso Technology Group plc] (CGWL)
-
Net Asset Value(s)
-
Imperial Capital Expands its Emerging Markets Sales & Trading Group
-
Imperial Capital Expands its Emerging Markets Sales & Trading Group
-
Perion Network (PERI) Reports Acquisition of Content IQ
-
Perion Acquires Content IQ and Its Breakthrough Pub-Tech Optimization Solution to Strategically Propel Disruptive Synchronized Digital Branding Offering
-
Canaccord Genuity Downgrades EnCana Corp. (ECA) to Hold
-
Little Green Pharma plans to list on the Australian Stock Exchange (ASX)
-
Little Green Pharma plans to list on the Australian Stock Exchange (ASX)
-
Form 8.3 - [Accesso Technology Group plc] (CGWL)
-
Canaccord Genuity Downgrades Hexcel Corp. (HXL) to Hold Following Merger
-
Illumina (ILMN) PT Raised to $345 at Canaccord Genuity
-
Castle Biosciences (CSTL) PT Raised to $38 at Canaccord Genuity
-
RADA Announces Closing of Public Offering of 4,819,052 Ordinary Shares Including Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Trakopolis Granted Approval and Vesting Order
-
Transaction in Own Shares
-
Inventus Mining Announces Update to Private Placement Financing
-
Net Asset Value(s)
-
Form 8.3 - [Accesso Technology Group plc] (CGWL)
-
Inventus Mining Announces Update to Private Placement Financing
-
Cortexyme to Present at the 3rd Annual Neuroscience Innovation Forum on January 12, 2020
-
MTBC Announces Acquisition of CareCloud, Closes its Largest Transaction to Date
-
MTBC Announces Acquisition of CareCloud, Closes its Largest Transaction to Date
-
RADA (RADA) Prices 4.19M Offering of Ordinary Shares at $5.25/Share
-
RADA Announces Pricing of Public Offering of Ordinary Shares
-
Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
-
SeaSpine Holdings (SPNE) Prices 6.8M Share Common Offering at $12.50/Sh
-
Intra-Cellular Therapies Prices Public Offering of Common Stock
-
SeaSpine Prices Public Offering of Common Stock
-
RADA Electronic Industries (RADA) Announces Proposed Share Offering
-
RADA Announces Proposed Public Offering of Ordinary Shares
-
SeaSpine Holdings (SPNE) Commences Public Offering of Common Stock
-
SeaSpine Commences Public Offering of Common Stock
-
ArcherDX Appoints Mark Massaro Chief Financial Officer
-
Form 8.3 - [Accesso Technology Group plc] (CGWL)
-
Canaccord Genuity Starts Sprout Social Inc. (SPT) at Buy
-
Canaccord Genuity Starts Bill.com Holdings Inc. (BILL) at Hold
-
Net Asset Value(s)
-
Musk defies skeptics, meets Tesla delivery goal; shares hit record
-
Inventus Mining Announces Private Placement Financing
-
Pre-Open Stock Movers 01/02: (PULM) (SAVA) (WATT) Higher; (DRRX) (SIG) Lower (more...)
-
MJardin Enters into Definitive Agreement for the Sale of its Cheyenne Cultivation Facility
-
Tesla (TSLA) PT Raised to 'Street High' $515 at Canaccord Genuity
-
Canaccord Genuity Downgrades Badger Meter (BMI) to Sell
-
Tesla says will start delivering China-made Model 3s to public on Jan. 7
-
Form 8.3 - Accesso Technology Group plc
-
TransGlobe Energy Corporation Announces an Update to a Significant Shareholder
-
Xebec Announces Closing of $23 Million Bought Deal Public Offering of Common Shares
-
Castle Biosciences (CSTL) PT Raised to $35 at Canaccord Genuity
-
Form 8.3 - Accesso Technology Group plc

